English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jan 19, 2026

AbbVie licenses RemeGen's cancer drug candidate for nearly $5 billion
+ Pharmaceuticals
Patient Daily | Jan 19, 2026

Researchers identify new TP53 mutations linked to rezatapopt resistance
+ Pharmaceuticals
Patient Daily | Jan 19, 2026

Study reveals role of PTRH2 gene in protecting maternal hearts during pregnancy
+ Pharmaceuticals
Patient Daily | Jan 19, 2026

Researchers find new mechanism controlling protein production in aggressive breast cancer
+ Pharmaceuticals
Patient Daily | Jan 19, 2026

Digital tools show promise in reducing alcohol and cannabis risks among young adults
+ Pharmaceuticals
Patient Daily | Jan 19, 2026

UC San Diego researchers identify protein vulnerability in aggressive breast cancer
+ Pharmaceuticals
Patient Daily | Jan 19, 2026

Kyoto University study links rare sugars to reduced alcohol intake in mice
+ Pharmaceuticals
Patient Daily | Jan 19, 2026

Gut bacteria shown to protect mice from post-influenza pneumonia

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes